Mike Blank

Catalent Pharma Solutions, Inc. engages in the development, manufacture, and sale of pharmaceutical products. It operates through the following segments: Development and Clinical Services, Oral Technologies, and Medication Delivery Solutions. The Development and Clinical Services segment manufactures, packs, stores distributes, and manages inventory for global clinical trials of drugs and biologics. The Oral Technologies segment formulates, develops, and manufactures prescription and consumer health products using various technologies. The Medication Delivery Solutions segment develops, formulates, and manufactures prefilled syringes and other injectable formats. The company was founded in 2002 and is headquartered in Somerset, NJ.

National Academy of Sciences operates as a private, nongovernmental institution that advises on issues related to science and technology. It provides independent, objective analysis and advice and conducts other activities to solve complex problems and inform public policy decisions. The firm also encourages education and research, recognize outstanding contributions to knowledge, and increase public understanding in matters of science. The company was founded on March 3, 1863 and is headquartered in Washington, DC.

The American Academy of Arts & Sciences is an organization that honors excellence and brings together leaders. The non-profit company is based in Cambridge, MA.

Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA.

Lawrence Berkeley National Laboratory engages on research of environmental studies, nanoscience, and quantitative biology, physics and nuclear energy. The lab is funded by the U.S. Department of Energy and managed by the University of California. It was founded in 1931 by Ernest Orlando Lawrence and is headquartered in Berkeley, CA.

Venn Biosciences Corp. engages in developing an artificial intelligence-driven mass spectrometry discovery and validation platform. Its products include VENN Vista, a glycoproteomic analysis; OpenPIP software, a neural network for automated mass spectrometry peak integration; and cancer liquid biopsy. The company was founded by Lieza Denan, Aldo Carrascoso, Carlito B. Lebrilla, and Carolyn R. Bertozzi in June 2017 and is headquartered in South San Francisco, CA.

GSK Equity Investment Ltd (GSK Equity) is a venture capital firm a subsidiary of GlaxoSmithKline Plc founded in 1985. The firm is headquartered in Reedwood City, California.

The National Academy of Medicine (United States) is based in Washington and is focused on improving the health and well-being of individuals through various initiatives. These initiatives include the clinician well-being collaborative, which aims to accelerate the implementation of a national plan for health workforce well-being, and the development of a code of conduct for the use of artificial intelligence in health care. The organization also provides resources to support meaningful community engagement in health and health care programs and policies. Recently, the National Academy of Medicine announced the appointment of Mandy Cohen, a member of the organization, as the director of the Centers for Disease Control and Prevention. Additionally, the organization has released a publication celebrating 50 years of progress in biomedical science, health, and health care.

American Chemical Society engages as a scientific society which supports scientific inquiry in the field of chemistry. The company was founded in 1876 and is headquartered in Washington, DC.

The American Society for Biochemistry and Molecular Biology, Inc. is an international non-profit scientific and educational organization based in Bethesda, MD. With over 11,000 members, the society is one of the largest molecular life science societies in the world. The society serves the scientific community through the publication of peer-reviewed journals and science news, organization of scientific meetings, advocacy for funding of basic research and education, support of career development and science education at all levels, promoting the diversity of individuals entering the scientific workforce, and celebrating important contributions and achievements in science and technology made by black scientists. The society also honors an outstanding scientist who has shown a sustained commitment to breaking down local and/or systemic barriers against scientists and students from historically marginalized or excluded groups. Founded in 1906, the society's mission is to advance the science of biochemistry and molecular biology and promote the understanding of the molecular nature of life processes.

The Broad Institute, Inc. engages in the provision of research and development in biomedicals to cure infectious disease. Its scientific areas include chemical biology and therapeutics, genome regulation, cellular circuity and epigenomics, medical and population genetics, and metabolism. The company was founded by Eric S. Lander, Eli Broad and Edythe Broad in 2003 and is headquartered in Cambridge, MA.

Grace Science Foundation is a biotechnology company that was founded in 2017 by Matt Wilsey and Dr. Carolyn Bertozzi. The private company is based in San Francisco, CA. The company focuses on developing novel therapies based on the function of NGLY1, a key enzyme involved in proteostasis. Grace Science Foundation's deep knowledge of the NGLY1 pathway enables them to identify new ways of treating NGLY1 deficiency as well as more common diseases.

Howard Hughes Medical Institute, Inc. engages in the provision of biomedical research services and science education programs. It funds grants to both institutions and individuals in support of a wide range of science and research-related initiatives, including precollege and undergraduate science education, pre- and post-doctoral research fellowships, and international research activities. The company was founded by Howard R. Hughes in 1953 and is headquartered in Chevy Chase, MD.

Palleon Pharmaceuticals, Inc. operates as biotechnology company. The firm discovers and develops immuno-oncology drugs, medicines, and therapies for the treatment of cancer diseases. It specializes in clinical development, and glyco-immune checkpoint inhibitors. The company was founded by Jim Broderick, Carolyn Bertozzi and Paul Crocker in 2015 and is headquartered in Waltham, MA.

Lycia Therapeutics, Inc. is a biotechnology company, which engages in the developing technology that utilizes lysosome-targeting chimeras. It uses LYTACs platform to discover and provide therapeutics that degrade extracellular and membrane-bound proteins that drive a range of difficult-to treat diseases, including cancers and autoimmune conditions. The company was founded by Carolyn R. Bertozzi in 2019 and is headquartered in San Diego, CA.

OmniAb Operations, Inc. operates as a drug discovery company. It provides pharmaceutical industry partners access to antibody repertoires and screening technologies to enable discovery of next-generation therapeutics. Its OmniAb platform includes the Biological Intelligence of its transgenic animals, including OmniRat, OmniChicken and OmniMouse, that have been genetically modified to generate antibodies with human sequences to facilitate development of human therapeutic candidates. The company is headquartered in Emeryville, CA.

Enable Biosciences, Inc. is a diagnostics company based in the United States. The private company is based in the United States. The American company develops and deploys bioassays for type 1 diabetes, COVID-19, and food allergy using licensed technology from UC. Enable Biosciences operates a CLIA certified high-complexity clinical reference laboratory and research facility. The company's proprietary diagnostics platform enables the ultrasensitive detection of biomarkers at the earliest stages of disease for optimal treatment timing. The company's fully automated high-throughput ultrasensitive and highly specific multiplex antibody detection analyzer uses its novel antibody detection by agglutination PCR (ADAP) chemistry to service clients in the infectious disease, autoimmunity, and allergy spaces. Enable has produced the independently-assessed world's best performing serologic tests for type 1 diabetes and HIV in oral fluid and other infectious diseases including Zika and Dengue. The company was founded by Jason Tsai, Carolyn R. Bertozzi, Peter Robinson, and David Seftel, with David Seftel serving as the CEO since incorporation.

ROTH Capital Partners LLC is a broker/dealer headquartered in Newport Beach, California. The firm was founded in 2001 and is a subsidiary of CR Financial Holdings, Inc. They offer institutional sales and trading services. Their broad institutional coverage includes investors in North America, Canada, UK, Europe and other international territories.

Cornell University is an educational institution that offers undergraduate and post graduate programs. It was founded in 1865 and is based in Ithaca, NY.

H. C. Wainwright & Co. LLC (H. C. Wainwright) is a full-service broker/dealer headquartered in New York City. The firm was founded in 1868 and is a subsidiary of HCWHC, Inc. H. C. Wainwright delivers industry insights and real-time execution to both public and private small and middle-sized global emerging market companies. With a focus on identifying buyers and sellers in illiquid and difficult to trade equities, the firm specializes in block trading and providing liquidity in these securities with as little market impact as possible.

Acrigen Biosciences, Inc. operates as a early-stage life science gene editing company. The company was founded by Joseph Bondy-Denomy in 2019 and is headquartered in Kensington, CA.

Optimer Pharmaceuticals LLC operates as a biopharmaceutical company. It is focused on discovering, developing, and commercializing innovative hospital specialty products. Optimer Pharmaceuticals primarily concentrates on developing DIFICID and other fidaxomicin products. The company was founded by Michael N. Chang in 1998 and is headquartered in Jersey City, NJ.

Firefly Bio, Inc. is an American company located in South San Francisco, CA. The firm specializes in degrader antibody conjugates which combine the unique strengths of ADCs with selective protein degraders. It was founded by Carolyn R. Bertozzi, John Flygare and Bernhard Geierstanger. Scott Hirsch is currently the CEO of the company.

Asceneuron SA operates as a biotechnology company. It develops therapeutics for orphan tauopathis and Alzheimer?s disease. The firm specializes in small molecule drug discovery for neurodegenerative diseases. The company was founded by Dirk Beher, Frank Murdoch Armstrong and Christoph Wiessner in October 2012 and is headquartered in Lausanne, Switzerland.

Accademia Nazionale dei Lincei engages in the provision of cultural studies. It carries out research activities, national and international conferences, meetings and seminars, offers awards and grants, and provides advice to public institutions. The company was founded by Federico Cesi in 1603 and is headquartered in Rome, Italy.

The National Academy of Inventors operates as a business association that promotes investors. The private company is based in Tampa.

Amphivena Therapeutics, Inc. provides drug discovery services. It develops tetravalent, T-cell redirecting bispecific antibodies for the treatment of hematologic malignancies. The firm’s’ lead drug candidate is AMV-564, a CD33/CD3-targeting treatment for acute myeloid leukemia (AML), which Amphivena is currently preparing to advance into clinical development. The company was founded by Jeanmarie Guenot in December 2012 and is headquartered in San Francisco, CA.

Comet Therapeutics, Inc. develops and commercializes treatments for patients suffering from metabolic, neurological and immunological disorders. The company was founded by Angellina Sekirnik and Enej Kuscer in 2008 and is headquartered in Cambridge, MA.

Inspirna, Inc. operates as a clinical stage biopharmaceutical company which develops molecule and antibody cancer therapeutics. It provides drugs for melanoma, colorectal and triple-negative breast cancers. The firm identifies novel cancer targets using a microRNA based target discovery platform that enable the identification and validation of novel post-transcriptionally regulated targets. The company was founded by Masoud Tavazoie, Sohail Tavazoie, Shahram Seyedin-Noor and Saeed Tavazoie in 2010 and is headquartered in New York, NY.

Founded in 1962, Catalent U.K. Packaging Ltd. is a subsidiary of Catalent, Inc. that provides packaging and protection solutions. The company is based in Swindon, UK.

Abingworth Management, Inc. invests in life sciences and biomedical companies. The firm's investment in enables technologies, devices and instrumentation as well as companies developing products in therapeutic areas. The company was founded in 1973 and is headquartered in Menlo Park, CA.

Catalent Indiana LLC manufactures biopharmaceutical products. It also manufactures cell culture, recovery and purification, prefilled syringe filling, vial filling and lyophilization, inspection, labeling and packaging. The company was founded in 2004 and is headquartered in Bloomington, IN.

DJO Finance LLC develops, manufactures and distributes medical devices with a products used for rehabilitation, pain management and physical therapy. The company was founded in 2006 and is headquartered in Vista, CA.